Staar, Ophtec Address Panel’s Phakic IOL Endothelial Cell Loss Concerns

FDA Ophthalmic Devices Panel concerns regarding endothelial cell loss associated with phakic intraocular lens implantation will delay review of Ophtec's Artisan phakic IOL by two months, the firm says